PATHOLOGY

Detailed explanation-1: -The combination of gemcitabine and cisplatin achieved a response rate of 22% plus an additional disease stabilization rate of 26% giving an overall disease control rate of 48%. The median survival was 10.8 mo with a 1-year survival rate of 40% which were encouraging in the majority of patients with metastatic disease.

Detailed explanation-2: -Surgery is the preferred treatment for gallbladder cancer and offers the best chance for a cure. For tumors that have not spread beyond the gallbladder, the most effective procedure is called a radical cholecystectomy.